Literature DB >> 35088362

Eyelid malignancies in young individuals: clinical peculiarities.

Débora F Biazim1, Midori H Osaki2,3, Don O Kikkawa4, Catherine Y Liu4, Fabio Leonardo1, Tammy H Osaki1,5.   

Abstract

OBJECTIVE: The incidence of malignant eyelid tumors is considerably increasing, even in young patients. The purpose of this study was to identify particularities in individuals under 40 years of age affected by eyelid malignancies.
METHODS: Clinical charts of patients under 40 years of age who underwent eyelid tumor excision from 2014 to 2020 in two reference centers, one in Brazil and one in the USA, were reviewed. Demographic and outcome measures included: age, gender, skin phototype, comorbidities, diagnosis, time until diagnosis, lesion location, recurrence and metastasis. In addition, associated characteristics, including chronic sun exposure, intentional tanning (outdoor or artificial), history of smoking, use of sunscreen, family history of skin cancer and exposure to pesticides or herbicides, were reviewed.
RESULTS: A total of 24 malignant eyelid tumors from 17 patients were identified. Twelve (70.6%) patients were female, and the most prevalent tumor was basal cell carcinoma (62.5%). Three (17.6%) patients had xeroderma pigmentosum and presented with multiple lesions. Family history of skin cancer was reported by 47% of patients. Prolonged sun exposure was reported by 41.2%; history of smoking and intentional tanning were reported by 23.5 and 17.6%, respectively, and might have played a role in carcinogenesis.
CONCLUSIONS: Although uncommon in young subjects, eyelid malignancies present some peculiarities in individuals under 40 years of age. Our results suggest that women with family history of skin cancer and history of chronic exposure to ultraviolet radiation are at risk. Association with genetic syndromes is also relevant among younger age groups.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Eyelid malignancies; Eyelid tumor; Young individuals

Mesh:

Year:  2022        PMID: 35088362     DOI: 10.1007/s10792-021-02184-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  2 in total

1.  Basal cell carcinoma on the eyelids: own experience.

Authors:  Joanna Salomon; Andrzej Bieniek; Eugeniusz Baran; Jacek C Szepietowski
Journal:  Dermatol Surg       Date:  2004-02       Impact factor: 3.398

2.  A retrospective study of 2228 cases with eyelid tumors.

Authors:  Sha-Sha Yu; Yun Zhao; Hong Zhao; Jin-Yong Lin; Xin Tang
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.